Rollover Protocol for Prior SU011248 Protocols
NCT00798889
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
314
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Sunitinib
Sponsor
Pfizer